The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.

Johnson & Johnson will spin off its $9.2B orthopedics business into a new company, DePuy Synthes, to focus on faster-growing ...

Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company within the next 18 ...

Split of unit making knee and hip replacements comes as US healthcare group seeks shift to higher-growth areas ...

Johnson & Johnson said it plans to separate its slower-growing orthopedics business from the rest of the company within 18 to ...

Johnson & Johnson is narrowing its focus again, nearly four years after peeling off its consumer health business.

Two years after spinning off its $15 billion consumer health unit as Kenvue, Johnson & Johnson is slimming down again by ...

Johnson & Johnson (NYSE: JNJ) announced today that it intends to separate its DePuy Synthes Orthopaedics business.

Jonhson and Johnson announced its intention to separate its orthopaedics business to enhance both the strategic and operational focus of each company, while also improving value for stakeholders. 1 ...

Johnson & Johnson is planning to separate its orthopedics business into a new company called DePuy Synthes. This will let J&J ...

Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate ...

Johnson & Johnson reported third-quarter earnings and revenue above analyst expectations, and announced it plans to spin off its Orthopaedics business.